Delivery Order SPE2DB20D2014-SPE2DB22FA39L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $6,519.84 under a Firm Fixed Price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $6,519.84 for TRIUMEQ 600-50-300 mg tablets in quantities of 30, with a firm fixed price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,525.99 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRIUMEQ 600-50-300 MG tablets (30-count units) with a ceiling value of $78,899.37. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,422.70 firm fixed-price delivery order is for the supply of TRIUMEQ 600-50-300 MG TABLET, a prescription medication, with an ultimate completion date of August 27, 2024. The contract is not set aside for any specific business classification. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $6,519.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRIUMEQ 600-50-300 MG TABLET in quantities of 30. The contract has an ultimate completion date of July 7, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $7,658.74 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRIUMEQ 600-50-300 MG TABLET UU 30S. This delivery order is part of an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the sole awardee, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC allows AmerisourceBergen Drug Corp to deliver a wide...
- The Defense Logistics Agency awarded a delivery order valued at $23,257.91 to AmerisourceBergen Drug Corp for 30-unit supplies of TRIUMEQ 600-50-300 mg tablets. This contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $12,275.46 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of TRIUMEQ TABLET UU 30S medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which enables the government to efficiently...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of pharmaceutical products, including TRIUMEQ 600-50-300 MG Tablets. The $11,726.97 firm fixed price delivery order has an ultimate completion date of August 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB22FA39LDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation, for the provision of TRIUMEQ 600-50-300 MG tablets. The $15,507.76 contract has an ultimate completion date of November 18, 2021. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a potential ceiling value of $999,999,999.00 that was awarded solely to the company by DLA. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 11/17/21 |